Full Text View
Tabular View
No Study Results Posted
Related Studies
Osteocel® Plus in eXtreme Lateral Interbody Fusion (XLIF®)
This study has been completed.
Study NCT00948532   Information provided by NuVasive

First Received on July 16, 2009.   Last Updated on May 17, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Degenerative Disc Disease
Back Pain
Additional conditions recognized in this trial
Intervertebral Disk Degeneration
More general conditions related to this trial
Bone Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neurologic Manifestations
Pain
Signs and Symptoms
Spinal Diseases
Interventions listed in this trial
biologic, Osteocel Plus
Sponsors listed in this trial
NuVasive


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services